Jefferies & Company
JEF
$52.98
+2.95%
Jefferies Financial Group Inc. is a full-service investment banking and capital markets firm operating in the Financial Services sector, with a core focus on investment banking and institutional trading services. The company has established itself as a prominent player in the North American middle market, capturing significant market share over the past decade through its role as a key advisor and financier for mid-sized corporations. The current investor narrative centers on the firm's resilience and strategic positioning amidst volatile capital markets, with recent attention driven by its role in steady deal flow, such as the Suja Life IPO filing, and its potential to benefit from M&A tailwinds as market conditions stabilize, positioning it as a more stable alternative to pure-play fintech disruptors facing headwinds.…
JEF
Jefferies & Company
$52.98
Related headlines
Investment Opinion: Should I buy JEF Today?
Rating: Hold. The core thesis is that JEF presents a high-risk, high-potential-reward bet on a capital markets recovery, but current volatility and cash flow concerns warrant caution despite an attractive valuation.
Supporting evidence includes a compelling forward P/E of 11.13x, which prices in a significant earnings rebound implied by the average analyst EPS estimate of $4.20. Revenue growth remains positive at 16.1% YoY, and analyst sentiment is persistently bullish. However, these positives are counterbalanced by a deeply negative free cash flow of -$1.71 billion, a low ROE of 6.72%, and severe stock price underperformance versus the broader market.
The thesis would upgrade to a Buy if the company demonstrates two consecutive quarters of positive free cash flow and stabilizes operating margins above 8%. It would downgrade to a Sell if revenue growth turns negative or if the debt-to-equity ratio climbs above 2.5. Relative to its own history and the cyclical nature of its business, the stock is fairly valued at current levels, reflecting a balanced view of recovery potential and substantial execution risk.
Sign up to view all
JEF 12-Month Price Forecast
JEF is a classic cyclical turnaround story caught between attractive valuation and troubling fundamentals. The forward P/E discount and recent revenue growth suggest the market is overly pessimistic, but the severe cash burn and earnings volatility validate that pessimism. The path of least resistance is a choppy, range-bound trade (base case) as investors await clearer signs of a sustainable capital markets recovery and cash flow inflection. The stance would upgrade to bullish on evidence of two consecutive quarters of positive operating cash flow and a confirmed breakout above the $58 resistance level. It would turn bearish on a breakdown below the $35 support coupled with a revenue growth deceleration.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Jefferies & Company's 12-month outlook, with a consensus price target around $68.87 and implied upside of +30.0% versus the current price.
Average Target
$68.87
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$42 - $69
Analyst target range
Analyst coverage for JEF is limited, with only 2 analysts providing estimates, indicating this is a smaller or less-followed name within the institutional landscape. The consensus sentiment, inferred from recent institutional ratings, leans bullish with firms like Goldman Sachs and UBS maintaining 'Buy' or 'Outperform' ratings, and Morgan Stanley upgrading to 'Overweight' in December 2025. The average revenue estimate for the period is $10.12 billion, with a wide range from $9.41 billion to $11.20 billion. The average EPS estimate is $4.20, ranging from $3.82 to $4.78. The wide target range for both revenue and EPS signals high uncertainty among the few covering analysts, reflecting the inherent volatility in capital markets revenues and the difficulty of forecasting investment banking deal flow and trading income. The recent pattern of reiterated bullish ratings (e.g., Oppenheimer, Goldman Sachs in March 2026) suggests analysts are maintaining a positive long-term view despite recent stock price weakness, possibly anticipating a cyclical recovery.
Bulls vs Bears: JEF Investment Factors
The investment debate for JEF centers on a compelling valuation disconnect versus severe operational volatility. The bull case is anchored in a deeply discounted forward P/E of 11.13x, solid recent revenue growth of 16.1%, and bullish analyst sentiment expecting an EPS recovery to $4.20. The bear case highlights extreme earnings instability, chronic market underperformance, and a deeply negative free cash flow of -$1.71 billion that questions financial sustainability. Currently, the bearish evidence appears stronger, given the stock's persistent downtrend, -22.33% YTD decline, and fundamental cash burn. The single most important tension is whether the anticipated cyclical recovery in capital markets activity materializes to validate the forward earnings estimates and reverse the cash flow drain, or if prolonged volatility continues to pressure margins and justify the stock's discounted multiple.
Bullish
- Deeply Discounted Valuation: The stock trades at a forward P/E of 11.13x, a significant discount to its trailing P/E of 17.25x, implying the market expects a strong earnings recovery. This forward multiple is also below its own historical range, such as the 24.69x seen in Q1 2025, suggesting the stock is priced for pessimism.
- Strong Recent Revenue Growth: Q1 2026 revenue grew 16.1% year-over-year to $2.87 billion, demonstrating resilience in its core investment banking and trading businesses. This growth occurred despite the volatile capital markets environment, highlighting the firm's ability to capture deal flow.
- Analyst Sentiment Remains Bullish: Despite limited coverage, major firms like Goldman Sachs, UBS, and Morgan Stanley maintain 'Buy' or 'Overweight' ratings, with recent reiterations in March 2026. The average analyst EPS estimate of $4.20 implies significant growth from the trailing twelve-month figure, supporting a positive long-term view.
- Oversold Technical Bounce Underway: The stock has rallied 19.17% over the past month, showing strong relative strength (+9.19 vs. SPY) after a steep decline. Trading near 38% of its 52-week range ($35.53-$71.04) suggests a potential mean reversion from deeply oversold levels.
Bearish
- Severe Earnings and Cash Flow Volatility: EBITDA swung from -$1.44 billion in Q4 2025 to +$269 million in Q1 2026, indicating extreme earnings instability driven by volatile 'other expenses'. Trailing twelve-month free cash flow is deeply negative at -$1.71 billion, signaling the company is consuming cash to fund operations.
- Chronic Underperformance vs. Market: The stock has significantly underperformed the SPY, with a 1-year return of +4.52% versus the SPY's +29.04%, resulting in a -24.52 relative strength. Year-to-date, the stock is down -22.33%, highlighting persistent selling pressure and weak momentum.
- High Financial Leverage and Low ROE: A debt-to-equity ratio of 2.25 indicates significant financial leverage, amplifying risks during economic downturns. Return on Equity (ROE) is a modest 6.72%, suggesting inefficient use of shareholder capital and weak profitability generation.
- Vulnerable to Capital Markets Cycle: As an investment bank, revenues are highly cyclical and dependent on M&A and IPO activity, which can dry up in volatile or recessionary markets. The recent -48.81% max drawdown underscores the stock's high sensitivity to financial sector stress.
JEF Technical Analysis
The prevailing price trend for JEF is a pronounced downtrend, characterized by a 1-year price change of only +4.52%, which significantly underperforms the SPY's +29.04% gain. The stock is currently trading at $49.29, which is approximately 38% of its 52-week range (between $35.53 and $71.04), indicating it is positioned much closer to its annual lows than its highs. This deep discount suggests the market is pricing in significant pessimism, presenting a potential value opportunity, though it also risks being a 'falling knife' if fundamental pressures persist. Recent momentum shows a sharp divergence, with a strong 1-month rally of +19.17% sharply contrasting with a -19.43% decline over the past 3 months. This positive short-term surge, which also generated a relative strength of +9.19 against the market, suggests a potential oversold bounce or mean reversion attempt, but it remains to be seen if this can reverse the longer-term negative trajectory established by the -22.33% year-to-date decline. Key technical levels are clearly defined, with major support at the 52-week low of $35.53 and formidable resistance at the 52-week high of $71.04. A sustained breakout above the recent recovery highs near $50 would be needed to signal a more durable recovery, while a breakdown below the March lows near $36 would confirm the resumption of the primary downtrend. The stock's inherent volatility is highlighted by its substantial -48.81% max drawdown, underscoring the elevated risk profile typical of financial sector stocks during market stress.
Beta
—
—
Max Drawdown
-48.8%
Largest decline past year
52-Week Range
$36-$71
Price range past year
Annual Return
+5.2%
Cumulative gain past year
| Period | JEF Return | S&P 500 |
|---|---|---|
| 1m | +21.2% | +9.1% |
| 3m | -10.1% | +6.8% |
| 6m | -2.8% | +9.9% |
| 1y | +5.2% | +30.5% |
| ytd | -16.5% | +8.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
JEF Fundamental Analysis
Revenue trajectory shows growth but with notable volatility; the most recent quarterly revenue (Q1 2026) was $2.87 billion, representing a solid 16.1% year-over-year increase. However, examining the multi-quarter trend reveals inconsistency, with revenue dipping from $2.95 billion in Q4 2025 to the current level. Segment data indicates Investment Banking ($1.19 billion) and Interest Revenue ($832 million) are the primary drivers, though the latter is highly sensitive to interest rate environments. This mixed growth profile reflects the cyclical nature of capital markets revenues. The company is profitable, with Q1 2026 net income of $175.2 million and a net margin of 6.1%. Gross margin was strong at 70.25% for the quarter, but operating margin was a thinner 6.34%, indicating high operating expenses. Profitability has been inconsistent, as evidenced by a negative EBITDA of -$1.44 billion in Q4 2025 swinging to a positive $269 million in Q1 2026, largely due to volatile 'other expenses' line items, making the path to stable earnings challenging. Balance sheet and cash flow health present a mixed picture; the company maintains a robust current ratio of 2.43 and a debt-to-equity ratio of 2.25, which is elevated but not uncommon for a leveraged financial firm. A significant concern is the trailing twelve-month free cash flow, which is deeply negative at -$1.71 billion, suggesting the company is consuming cash to fund operations or investments. Return on equity (ROE) is a modest 6.72%, indicating less efficient use of shareholder capital in the recent period.
Quarterly Revenue
$2.9B
2026-02
Revenue YoY Growth
+0.16%
YoY Comparison
Gross Margin
+0.70%
Latest Quarter
Free Cash Flow
$-1.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is JEF Overvalued?
Given the company's positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 17.25x, while the forward PE is notably lower at 11.13x. This substantial gap implies the market expects a significant earnings recovery, with forward earnings estimates embedding growth expectations as capital markets activity potentially improves. Compared to sector averages, JEF's trailing PE of 17.25x and Price-to-Sales (PS) ratio of 1.13x are not directly comparable without a provided industry benchmark, but the PS ratio appears reasonable for a financial services firm. The forward PE discount suggests the market is not assigning a premium, likely due to the earnings volatility and the cyclical nature of its investment banking and trading businesses. Historical context shows the current trailing PE of 17.25x is below the higher end of its own historical range observed in recent quarters, such as the 24.69x seen in Q1 2025. This positioning near the lower end of its historical valuation band suggests the market is pricing in subdued expectations, possibly reflecting concerns over cyclical headwinds or execution risks, which could represent a value opportunity if the fundamental outlook improves.
PE
17.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 6x~147x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced, centered on extreme earnings volatility and cash consumption. EBITDA swung wildly from -$1.44 billion to +$269 million in consecutive quarters, making reliable forecasting difficult. More critically, trailing twelve-month free cash flow is -$1.71 billion, indicating the business is not self-funding and relies on external financing or balance sheet drawdowns. While the current ratio of 2.43 provides a liquidity buffer, the elevated debt-to-equity of 2.25 amplifies downside risk if profitability does not stabilize.
Market & Competitive Risks stem from JEF's pure-play exposure to the cyclical capital markets business. The stock's -48.81% max drawdown and significant underperformance versus the SPY (-24.52 relative strength over 1 year) demonstrate high sensitivity to financial sector sentiment and deal flow. Trading at a forward P/E of 11.13x, the market is not assigning a premium, reflecting concerns over this cyclicality and competitive pressures from larger bulge-bracket banks. A failure of the anticipated M&A recovery to materialize could lead to further valuation compression.
Worst-Case Scenario involves a protracted downturn in capital markets activity coinciding with a recession, leading to a collapse in investment banking fees and trading income. This could trigger consecutive quarterly losses, force a dividend cut from the current 3.05% yield, and lead to credit rating concerns due to the high debt load. In this adverse scenario, the stock could realistically retest its 52-week low of $35.53, representing a downside of approximately -28% from the current price of $49.29. A breach of this level could see further declines toward the $30 range, aligning with the analyst low EPS target scenario.
FAQ
The key risks are, in order of severity: 1) Financial Sustainability Risk: The company is burning cash, with trailing FCF of -$1.71 billion, raising questions about its funding needs. 2) Cyclical Revenue Risk: As an investment bank, its revenues are directly tied to M&A and IPO activity, which can collapse in downturns. 3) Leverage and Profitability Risk: A debt-to-equity ratio of 2.25 amplifies losses, while a low ROE of 6.72% shows poor capital efficiency. 4) Execution and Volatility Risk: Extreme quarterly EBITDA swings (from -$1.44B to +$269M) make the stock highly volatile and difficult to forecast.
The 12-month forecast is bifurcated, with a base case target range of $50-$58 (50% probability), a bull case of $65-$71 (30% probability), and a bear case of $35-$42 (20% probability). The base case, which is most likely, assumes a modest capital markets recovery where JEF meets analyst revenue estimates of ~$10.12B but continues to struggle with high costs and cash flow. The forecast hinges almost entirely on the trajectory of investment banking deal flow and the company's ability to control operating expenses. A breakout above $58 would signal the bull case is unfolding.
JEF appears fairly valued to slightly undervalued based on forward earnings, but this discounts significant risk. The forward P/E of 11.13x is a steep discount to the trailing P/E of 17.25x and its own historical multiples (e.g., 24.69x in Q1 2025), suggesting the market is pricing in low expectations. The Price-to-Sales ratio of 1.13x is reasonable for a financial firm. However, this valuation reflects well-understood flaws: extreme cyclicality, cash burn, and high leverage. The market is paying a fair price for a volatile, turnaround-dependent business, not a deep-value bargain.
JEF is a high-risk, high-potential-reward investment that is only a good buy for specific investors. The stock offers a compelling valuation with a forward P/E of 11.13x and analyst targets implying significant upside to an average EPS of $4.20. However, it comes with substantial risks, including a -$1.71 billion trailing free cash flow burn, severe earnings volatility, and a -48.81% max drawdown. It could be a good buy for contrarian, risk-tolerant investors who believe in a strong 2026 capital markets recovery and can tolerate further volatility. Conservative investors should avoid it.
JEF is primarily suitable for a long-term (3+ year) investment horizon for investors betting on a full capital markets cycle recovery. Its high volatility (evidenced by the -48.81% drawdown), cyclical nature, and lack of a stable dividend (3.05% yield) make it a poor fit for short-term trading or income investing. The long-term thesis requires patience for the company to navigate through volatility, improve cash flow, and ultimately re-rate as profitability stabilizes. A short-term trader might play the oversold bounce, but the fundamental noise makes timing exceptionally difficult.
